Results 101 to 110 of about 281,033 (233)
Brain network efficiency is influenced by pathological source of corticobasal syndrome [PDF]
arXiv, 2016 Multimodal neuroimaging studies of corticobasal syndrome using volumetric MRI and DTI successfully discriminate between Alzheimer's disease and frontotemporal lobar degeneration but this evidence has typically included clinically heterogeneous patient cohorts and has rarely assessed the network structure of these distinct sources of pathology.
arxiv
A NEW RATING SCALE FOR THE ASSESSMENT OF THE ALCOHOL-WITHDRAWAL SYNDROME (AWS SCALE) [PDF]
, 1997 T. Wetterling +7 more
openalex +1 more source
Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol
Journal of the Formosan Medical Association, 2018 Gamma-hydroxybutyrate (GHB) is a synthetic drug used mainly for recreational purpose. Although the prevalence of GHB abuse is low in Taiwan, GHB has become increasingly popular in certain subpopulations such as clubbers and men who have sex with men (MSM)
Po-Chiao Liao +2 more
doaj
Properties of Syndrome Distribution for Blind Reconstruction of Cyclic Codes [PDF]
arXiv, 2017 In the problem of blind reconstruction of channel codes, the receiver does not have the knowledge of the channel code used at the transmitter and the aim is to identify this unknown channel code corresponding to the given received sequence. In this paper, we study this blind reconstruction problem for binary cyclic codes.
arxiv
Withdrawal syndrome following midazolam infusion [PDF]
, 1995 Ph. Hantson, J. L. Clemessy, F.J. Baud
openalex +1 more source
Research on Addiction, 2012 Introduction: Orexin neuropeptide has a role in opioid withdrawal behaviors. Orexin-expressing neurons that are present in the hypothalamic nuclei send dense projections to the Locus Coeruleus (LC).
Hosin Azizi +2 more
doaj
Severe Withdrawal Syndrome Possibly Associated With Cessation of a Midazolam and Fentanyl Infusion [PDF]
, 1995 Murray P. Ducharme, Paul J. Munzenberger
openalex +1 more source
Iranian Journal of Medical Sciences, 2015 Background: Herbal medical compounds and their major constituent have been used in the management and treatment of opioid withdrawal syndrome and pain.
Majid Motaghinejad +4 more
doaj
The cannabis withdrawal syndrome: current insights
Substance Abuse and Rehabilitation, 2017 Udo Bonnet,1,2 Ulrich W Preuss3,4 1Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Evangelisches Krankenhaus Castrop-Rauxel, Academic Teaching Hospital of the University of Duisburg-Essen, Castrop-Rauxel, 2Department of Psychiatry and
Bonnet U, Preuss UW
doaj